Valuation: Ecomat Inc.

Market Cap 419K 359K 335K 307K 577K 40.1M 589K 3.97M 1.55M 20.09M 1.57M 1.54M 66.53M P/E 2022
-14.8x
P/E 2023 -25x
Enterprise Value 835K 715K 667K 612K 1.15M 79.86M 1.17M 7.91M 3.08M 40.02M 3.13M 3.07M 133M EV / Sales 2022
-
EV / Sales 2023 6,589,581x
Free-Float
8.59%
Yield 2022 *
-
Yield 2023 -
Manager TitleAgeSince
Chief Executive Officer 43 30/09/2022
Director TitleAgeSince
Chairman 43 30/09/2022
Change 5-day change 1-year change 3-year change Capi.($)
-57.14%-46.43% - - 714
-1.09%-4.49%+115.54% - 1.1B
-1.78%-4.10%-33.72%+95.56% 633M
+0.29%+7.83%-32.17%+263.32% 565M
-0.90%-7.19%-11.49% - 72.51M
Average -12.15%-0.58%+9.54%+179.44% 591.89M
Weighted average by Cap. -1.01%-0.22%+36.50%+174.67%

Financials

2022 2023
Net sales - 0.42 0.36 0.34 0.31 0.58 40.61 0.6 4.02 1.57 20.35 1.59 1.56 67.38
Net income -115K -98.12K -91.55K -84.01K -158K -10.97M -161K -1.09M -423K -5.5M -430K -421K -18.19M -89.92K -76.99K -71.83K -65.91K -124K -8.6M -126K -852K -332K -4.31M -338K -330K -14.28M
Net Debt 191K 164K 153K 140K 263K 18.28M 268K 1.81M 706K 9.16M 718K 702K 30.34M 416K 356K 332K 305K 572K 39.77M 584K 3.94M 1.54M 19.93M 1.56M 1.53M 65.98M
Logo Ecomat Inc.
Ecomax, Inc. is engaged in selling and distributing Rocitin NMN products to customers in the Territory. Rocitin NMN is a nutritional supplement manufactured by Pharmazeutische Fabrik Evers GmbH & Co. KG, a German company. Each bottle contains 60 capsules, 10080 mg of NMN. NMN, as β-Nicotinamide Mononucleotide exists in some fruits, vegetables, and poultry. It is a molecule naturally occurring in all life forms and can be transformed into a significant coenzyme NAD+ within cells, which is important to human metabolism. Its research, including Nicotinamide mononucleotide (NMN) as an anti-aging health product has shown that NAD+ levels in the body will decrease with age, and that exogenous supplementation of NMN enhances NAD+ levels and thus the function of human cells. In addition, NMN also helps to repair broken DNA, regulate the stability of DNA and cell death, and improve neurodegenerative and metabolic conditions.
Employees
-